Aclaris Therapeutics
ACRS
#8329
Rank
โ‚ฌ0.13 B
Marketcap
1,95ย โ‚ฌ
Share price
-5.96%
Change (1 day)
164.15%
Change (1 year)

Revenue for Aclaris Therapeutics (ACRS)

Revenue in 2024 (TTM): โ‚ฌ29.46 Million

According to Aclaris Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ30.4 Million. In 2023 the company made a revenue of โ‚ฌ28.26 Million an increase over the revenue in the year 2022 that were of โ‚ฌ27.73 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aclaris Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ29.46 M4.23%
2023 โ‚ฌ28.26 M1.92%
2022 โ‚ฌ27.73 M364.6%
2021 โ‚ฌ5.96 M13.28%
2020 โ‚ฌ5.26 M39.66%
2019 โ‚ฌ3.77 M-54.95%
2018 โ‚ฌ8.37 M497.08%
2017 โ‚ฌ1.4 M
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA